<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04617730</url>
  </required_header>
  <id_info>
    <org_study_id>CE3220.</org_study_id>
    <nct_id>NCT04617730</nct_id>
  </id_info>
  <brief_title>Efficacy of the Mepitel® Film on the Prevention of Radiodermatitis in the Inguinal Fold.</brief_title>
  <official_title>Randomized Trial to Quantify the Efficacy of the Safetac® Product Mepitel® Film on the Prevention of Radiodermatitis in the Inguinal Fold.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jules Bordet Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jules Bordet Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to quantify the efficiency of the Safetac product Mepitel® Film on the prevention&#xD;
      of radiodermatitis for cancer patients treated with external beam radiation therapy near the&#xD;
      inguinal fold(s). Previous studies have looked into the differences in skin reactions for&#xD;
      Mepitel® Film versus hydro-active colloid gel in breast cancer [1, 2] and head and neck&#xD;
      cancer [3]. In breast cancer, the prevalence of radiation induced dermatitis has strongly&#xD;
      decreased due to of modern radiotherapy techniques and fractionation. In the groin, however,&#xD;
      this is not the case, and radiation dermatitis remains an important problem. To the best of&#xD;
      our knowledge, no previous study has looked into the efficiency of a prophylactic Mepitel®&#xD;
      Film protocol in the inguinal fold. The goal of this study is to evaluate whether the&#xD;
      Mepitel® Film offers a lower degree of radiation-induced dermatitis compared to hydro-active&#xD;
      colloid gel and thereby challenging the gold standard.&#xD;
&#xD;
      References:&#xD;
&#xD;
        1. Herst, P., Bennett, N., Sutherland, A., Peszynski, R., Paterson, D. and Jasperse, M.&#xD;
           (2014). Prophylactic use of Mepitel Film prevents radiation-induced moist desquamation&#xD;
           in an intra-patient randomised controlled clinical trial of 78 breast cancer patients.&#xD;
           Radiotherapy and Oncology, 110(1), pp.137-143.&#xD;
&#xD;
        2. Møller, P., Olling, K., Berg, M., Habæk, I., Haislund, B., Iversen, A., Ewertz, M.,&#xD;
           Lorenzen, E. and Brink, C. (2018). Breast cancer patients report reduced sensitivity and&#xD;
           pain using a barrier film during radiotherapy - A Danish intra-patient randomized&#xD;
           multicentre study. Technical Innovations &amp; Patient Support in Radiation Oncology, 7,&#xD;
           pp.20-25.&#xD;
&#xD;
        3. Wooding, H., Yan, J., Yuan, L., Chyou, T., Gao, S., Ward, I. and Herst, P. (2018). The&#xD;
           effect of Mepitel Film on acute radiation-induced skin reactions in head and neck cancer&#xD;
           patients: a feasibility study. The British Journal of Radiology, 91(1081), p.20170298.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2024</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevention of grade 2.5 RTOG radiodermatitis</measure>
    <time_frame>Post 25 sessions</time_frame>
    <description>To evaluate and quantify the influence of the Mepitel® Film dressing on the prevention of patchy moist desquamation (grade 2.5 RTOG) radiodermatitis in the inguinal fold.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to radiodermatitis apparition</measure>
    <time_frame>At the end of treatment</time_frame>
    <description>To analyze the time it takes for the patchy moist desquamation (grade 2.5 RTOG) to appear and to evaluate whether it occurs later in the Mepitel® Film group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healing time</measure>
    <time_frame>3 months post treatment</time_frame>
    <description>To analyze the time that the patchy moist desquamation takes to heal and to evaluate if the Mepitel® film group can heal faster.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Radiodermatitis</condition>
  <condition>Radiation Toxicity</condition>
  <condition>Radiotherapy Side Effect</condition>
  <arm_group>
    <arm_group_label>Control arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Interventional arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mepitel® film</intervention_name>
    <description>This study is a comparative study between the standard procedure, which is to prescribe a hydro-active colloidal gel called Flamigel® to be applied to the irradiated area, and the use of Mepitel® Film.</description>
    <arm_group_label>Interventional arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Flamigel®</intervention_name>
    <description>The control arm will be treated according to the standard of care.</description>
    <arm_group_label>Control arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with external beam radiotherapy of the bilateral inguinal nodal region, with&#xD;
             at least 25 fractions of 1.8-2Gy per fraction.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Re-irradiation.&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  Patients under the age of 18.&#xD;
&#xD;
          -  Patients not willing to participate (no informed consent).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gitte Van de Ven, MSc</last_name>
    <phone>02 541 3882</phone>
    <phone_ext>+32</phone_ext>
    <email>gitte.vandeven@bordet.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Clémence Al Wardi, PhD</last_name>
    <phone>02 541 3981</phone>
    <phone_ext>+32</phone_ext>
    <email>clemence.alwardi@bordet.be</email>
  </overall_contact_backup>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>November 2, 2020</study_first_submitted>
  <study_first_submitted_qc>November 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2020</study_first_posted>
  <last_update_submitted>November 2, 2020</last_update_submitted>
  <last_update_submitted_qc>November 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Radiodermatitis</keyword>
  <keyword>Mepitel film</keyword>
  <keyword>Inguinal fold</keyword>
  <keyword>Radiotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Radiodermatitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

